Emcure Pharmaceuticals Ltd (EMCURE) — Free Cash Flow Generation Index
Emcure Pharmaceuticals Ltd (EMCURE) has a Free Cash Flow Generation Index of 0.50x as of September 2025. Free cash flow of Rs1.27 Billion represents 0% of operating cash flow (Rs2.56 Billion). Read Emcure Pharmaceuticals Ltd debt and liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Emcure Pharmaceuticals Ltd Free Cash Flow Generation Index (2022–2026)
Historical FCF Generation Index trend for Emcure Pharmaceuticals Ltd across 5 annual periods. Explore Emcure Pharmaceuticals Ltd (EMCURE) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Emcure Pharmaceuticals Ltd (2022–2026)
Year-by-year Free Cash Flow Generation Index for Emcure Pharmaceuticals Ltd. For the full company profile including market capitalisation, see Emcure Pharmaceuticals Ltd market cap and net worth.
| Year | FCG Index | Free Cash Flow (INR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.58x | Rs4.90 Billion | Rs8.51 Billion | Rs3.61 Billion | ▲ +10.3% |
| 2025 | 0.52x | Rs4.45 Billion | Rs8.52 Billion | Rs4.07 Billion | ▼ -27.5% |
| 2024 | 0.72x | Rs7.90 Billion | Rs10.97 Billion | Rs3.07 Billion | ▲ +56.6% |
| 2023 | 0.46x | Rs3.43 Billion | Rs7.47 Billion | Rs4.03 Billion | ▼ -4.8% |
| 2022 | 0.48x | Rs3.71 Billion | Rs7.68 Billion | Rs3.97 Billion | — |